Valley Gold Master Fund L. Sun Purchases 408,006 Shares of Boston Scientific Corporation (BSX) Stock
Boston Scientific Corporation (NYSE:BSX) insider Valley Gold Master Fund L. Sun acquired 408,006 shares of the company’s stock in a transaction dated Tuesday, November 28th. The stock was acquired at an average price of $0.45 per share, for a total transaction of $183,602.70.
Boston Scientific Corporation (NYSE BSX) traded down $0.13 during mid-day trading on Friday, reaching $26.15. The company had a trading volume of 16,180,000 shares, compared to its average volume of 8,300,000. Boston Scientific Corporation has a fifty-two week low of $20.03 and a fifty-two week high of $29.93. The firm has a market capitalization of $35,910.00, a P/E ratio of 21.54, a PEG ratio of 2.03 and a beta of 0.99. The company has a current ratio of 0.72, a quick ratio of 0.50 and a debt-to-equity ratio of 0.58.
Boston Scientific (NYSE:BSX) last released its earnings results on Thursday, October 26th. The medical equipment provider reported $0.31 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.31. Boston Scientific had a return on equity of 23.60% and a net margin of 9.55%. The business had revenue of $2.22 billion for the quarter, compared to the consensus estimate of $2.21 billion. During the same period last year, the business earned $0.27 earnings per share. The firm’s revenue for the quarter was up 5.6% compared to the same quarter last year. research analysts predict that Boston Scientific Corporation will post 1.25 EPS for the current fiscal year.
A number of equities analysts have recently commented on BSX shares. BidaskClub lowered Boston Scientific from a “hold” rating to a “sell” rating in a research note on Saturday, August 26th. Royal Bank Of Canada reiterated a “buy” rating and issued a $31.00 price objective on shares of Boston Scientific in a research note on Friday, September 1st. Zacks Investment Research upgraded Boston Scientific from a “sell” rating to a “buy” rating and set a $33.00 price objective on the stock in a research note on Friday, October 20th. Jefferies Group reiterated a “hold” rating on shares of Boston Scientific in a research note on Thursday, September 7th. Finally, BMO Capital Markets reiterated a “buy” rating and issued a $30.00 price objective on shares of Boston Scientific in a research note on Friday, October 13th. One investment analyst has rated the stock with a sell rating, four have given a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $30.61.
A number of hedge funds have recently added to or reduced their stakes in the stock. Comerica Securities Inc. grew its position in Boston Scientific by 0.9% during the second quarter. Comerica Securities Inc. now owns 11,478 shares of the medical equipment provider’s stock worth $318,000 after buying an additional 99 shares in the last quarter. ETRADE Capital Management LLC boosted its holdings in Boston Scientific by 1.7% during the second quarter. ETRADE Capital Management LLC now owns 10,079 shares of the medical equipment provider’s stock valued at $279,000 after purchasing an additional 171 shares in the last quarter. Krilogy Financial LLC boosted its holdings in Boston Scientific by 5.9% during the second quarter. Krilogy Financial LLC now owns 7,680 shares of the medical equipment provider’s stock valued at $213,000 after purchasing an additional 430 shares in the last quarter. Wetherby Asset Management Inc. boosted its holdings in Boston Scientific by 3.9% during the second quarter. Wetherby Asset Management Inc. now owns 13,788 shares of the medical equipment provider’s stock valued at $382,000 after purchasing an additional 523 shares in the last quarter. Finally, Greenwood Capital Associates LLC boosted its holdings in Boston Scientific by 1.1% during the second quarter. Greenwood Capital Associates LLC now owns 53,330 shares of the medical equipment provider’s stock valued at $1,478,000 after purchasing an additional 564 shares in the last quarter. 90.55% of the stock is currently owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by Watch List News and is the sole property of of Watch List News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.watchlistnews.com/valley-gold-master-fund-l-sun-purchases-408006-shares-of-boston-scientific-corporation-bsx-stock/1740013.html.
About Boston Scientific
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology.
Receive News & Ratings for Boston Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.